Integrated Biosciences is a biotechnology company dedicated to developing next-generation therapeutics targeting aging and age-related diseases. By integrating synthetic biology, chemistry, and machine learning, the company accelerates the discovery of novel small molecules with exceptional precision and speed. Their proprietary platform focuses on cellular stress responses and senescence, addressing traditionally challenging biological targets.
Archon Biosciences is a biotechnology company dedicated to advancing healthcare through innovative solutions in molecular diagnostics and personalized medicine. Their primary focus is on developing cutting-edge technologies that enable precise and rapid detection of various diseases, thereby facilitating early intervention and tailored treatment plans.
Differential Bio is pioneering the integration of biology and computation to revolutionize biomanufacturing. Their platform serves as the computational backbone for applying BioAI to regenerative manufacturing, enabling a shift from traditional trial-and-error methods to predictive, digital-first experimentation. This approach accelerates the development of biomanufactured products, making the process faster, more cost-effective, and smarter.
PolyModels Hub is a British software startup specializing in SaaS solutions for pharmaceutical process development. Their platform leverages artificial intelligence to assist scientists in modeling, simulating, and gaining insights across all protocols involved in transforming chemical compounds into safe drug products.
Nanite is a pioneering biotechnology company specializing in the development of non-viral gene delivery systems. Their proprietary platform, SAYER™, integrates artificial intelligence with high-throughput experimental and computational methods to design programmable polymer nanoparticles (PNPs). These PNPs are engineered to deliver a wide range of genetic cargoes with tissue specificity, offering a safer and more efficient alternative to traditional viral vectors. By harnessing AI-driven design,
Formation Bio is a pharmaceutical company dedicated to revolutionizing drug development by integrating advanced technology and artificial intelligence (AI) across the entire development lifecycle. By leveraging a modern data stack, large language models (LLMs), and AI agents, Formation Bio aims to accelerate the delivery of new treatments to patients more efficiently.
Chemix is revolutionizing electric vehicle (EV) battery development by integrating artificial intelligence (AI) to expedite the design process. Traditional battery development is often slow, labor-intensive, and costly. By leveraging AI, Chemix accelerates this process, reducing development time by a factor of ten. Their battery designs are compatible with existing lithium-ion manufacturing infrastructure, facilitating a seamless transition from research and development to mass production. Commi
Ignota Labs is a pioneering company dedicated to revitalizing promising yet abandoned drug candidates by addressing safety concerns that have halted their development. Leveraging their proprietary AI platform, SAFEPATH, Ignota Labs integrates deep learning with bioinformatics and cheminformatics to uncover and resolve the underlying mechanisms of drug toxicity. This innovative approach enables the company to rescue drugs that have failed in preclinical or early-phase clinical trials due to safet
CytoReason is a pioneering technology company specializing in the development of computational disease models that simulate human diseases at the cellular and tissue levels. By integrating vast datasets, including omics data and cell-focused natural language processing, CytoReason's platform provides a comprehensive understanding of disease mechanisms, patient variability, and treatment effects. This innovative approach enables pharmaceutical and biotech companies to identify new therapeutic tar
Achira is a biotechnology company revolutionizing drug discovery by developing atomistic foundation simulation models that integrate machine learning, quantum chemistry, and physics-based simulations. This innovative approach aims to overcome the limitations of traditional biomolecular simulations and the data constraints of pure machine learning models, thereby accelerating the identification and development of therapeutic compounds.
Biolevate is a pioneering company dedicated to integrating ethical artificial intelligence (AI) into the healthcare sector, aiming to create simple, secure, and collaborative solutions that accelerate medical advancements for a more accessible world. By harnessing the power of AI, Biolevate addresses the complex challenges faced by the life sciences industry, offering tailored solutions that enhance efficiency, compliance, and innovation.
Reshape Biotech offers an AI-powered platform that automates the imaging and analysis of petri and microtiter plates, enabling laboratories to capture high-resolution images, extract data instantly, and obtain reliable results.
ZipBio is a biotechnology company founded in 2023, dedicated to revolutionizing therapeutic development through the use of generative AI. Their proprietary COMPACT™ platform compresses complex biological structures into smaller, de novo-designed proteins that retain full functionality. This innovation addresses the size limitations of traditional therapeutics, enhancing delivery and effectiveness for hard-to-treat diseases.
Leash Biosciences is a biotechnology company dedicated to revolutionizing drug discovery by integrating machine learning with extensive biochemical data. By screening millions of compounds against thousands of proteins, Leash generates billions of data points, creating a rich dataset ideal for training advanced machine learning models. This approach aims to bridge the existing data gap in medicinal chemistry, facilitating the rapid design of novel small molecule therapeutics.
Quartz RE-LIMS is a Laboratory Information Management System built for reliability and quality assurance labs, designed and structured around qualification plans and multi-step job workflows. RE-LIMS is configured to match each lab's qualification process. Qualification plans can be generated on the fly, built from templates, or created from blank starting points, and individual job steps can be added or removed as a plan takes shape. A Resource Planning Manager includes a sandbox mode, letting
Quartz CH-LIMS is a Laboratory Information Management System built for chemical analysis labs, supporting workflows such as ultrapure water testing, product ecology and safety analysis, incoming materials inspection, and prohibited chemicals certification. CH-LIMS is highly configurable and supports multiple chemical analysis techniques, including ICP-MS and IC, importing data files directly from a wide range of laboratory instruments rather than requiring manual data entry. The system provides
Quartz FA-LIMS is a Laboratory Information Management System built for Imaging labs like Failure Analysis or Materials Characterization labs. It was designed for the image-intensive nature of these labs and the complex, customized reporting these labs need to deliver to internal engineering teams and external clients. FA-LIMS is configured to match each lab's specific workflow, terminology, and job structure rather than forcing labs to adapt to a fixed data model. Its integration with Quartz PC
LIMS Digital is a Unified SaaS-based Laboratory Software Suite designed to revolutionize laboratory operations across diverse sectors. Built to meet the complex needs of Medical and Diagnostic Laboratories, Biorepositories, Environmental Labs, and the Cannabis Industry, LIMS Digital delivers scalable, secure, and fully customizable solutions. Whether you're focused on Clinical Diagnostics, managing sample workflows, or ensuring regulatory compliance, LIMS Digital simplifies every stage—from sam
PathoGoldCloud is a cloud-based lab software enabling instant report generation, secure sharing, and QR access for modern diagnostics.
AQChemSim is an advanced computational platform developed by SandboxAQ that revolutionizes the discovery and optimization of chemicals and materials. By integrating Large Quantitative Models (LQMs) derived from artificial intelligence and physics-based methodologies, AQChemSim accelerates innovation across various industries, including catalyst development, battery technology, and alloy design. This approach offers a groundbreaking alternative to traditional materials discovery by combining data